KHRN.H Stock Financial Analysis - Khiron Life Sciences Corp. (TSXV) Stock

Overview

Khiron Life Sciences Corp., based in Canada, operates primarily in the medical cannabis industry. This company is notably focused on the Latin American market, though it has a growing presence in Europe as well. Specializing in both the cultivation and production of medical cannabis, Khiron is particularly centered on developing and commercializing top-quality cannabis products for medical use. One of its key projects includes the development of clinics that not only distribute but also support the use of medicinal cannabis among patients, integrating comprehensive health services. This strategic approach aims to bolster patient access and adherence to treatment regimens, ensuring compliance with regulatory frameworks across its operational territories.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Khiron Life Sciences Corp. as of September 30, 2022 is 16.14 MM.
The operating income for Khiron Life Sciences Corp. as of September 30, 2022 is -17.44 MM.
The net income for Khiron Life Sciences Corp. as of September 30, 2022 is -30.66 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2022-09-30	16.14	-17.44	-30.66
2022-06-30	16.27	-18.54	-30.42
2022-03-31	14.60	-20.05	-33.05
2021-12-31	12.79	-20.52	-33.13
2021-09-30	11.68	-16.89	-16.00
2021-06-30	10.09	-18.84	-19.38
2021-03-31	8.95	-19.84	-20.30
2020-12-31	8.02	-23.61	-24.04
2020-09-30	8.01	-31.14	-29.90
2020-06-30
2020-03-31

Income Statement: EPS

The earnings per share basic for Khiron Life Sciences Corp. as of September 30, 2022 is -0.16.
The earnings per share diluted for Khiron Life Sciences Corp. as of September 30, 2022 is -0.16.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2022-09-30	-0.16	-0.16
2022-06-30	-0.17	-0.16
2022-03-31	-0.19	-0.19
2021-12-31	-0.20	-0.20
2021-09-30	-0.11	-0.11
2021-06-30	-0.14	-0.14
2021-03-31	-0.16	-0.16
2020-12-31	-0.20	-0.20
2020-09-30	-0.26	-0.26
2020-06-30	-0.29	-0.29
2020-03-31	-0.34	-0.34

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Khiron Life Sciences Corp. as of September 30, 2022 is -15.01 MM.
The cash from investing activities for Khiron Life Sciences Corp. as of September 30, 2022 is -3.13 MM.
The cash from financing activities for Khiron Life Sciences Corp. as of September 30, 2022 is 4.93 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2022-09-30	-15.01	-3.13	4.93
2022-06-30	-14.82	-2.47	15.14
2022-03-31	-15.01	-2.29	10.95
2021-12-31	-20.40	-2.09	10.89
2021-09-30	-20.98	-1.38	22.97
2021-06-30	-20.99	-1.45	11.81
2021-03-31	-22.84	3.54	12.39
2020-12-31	-24.53	24.87	12.17
2020-09-30	-27.29	26.80	-0.81
2020-06-30
2020-03-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Management Effectiveness

The roa for Khiron Life Sciences Corp. as of September 30, 2022 is -0.46.
The roe for Khiron Life Sciences Corp. as of September 30, 2022 is -0.56.
The roic for Khiron Life Sciences Corp. as of September 30, 2022 is -1.03.
The croic for Khiron Life Sciences Corp. as of September 30, 2022 is -0.45.
The ocroic for Khiron Life Sciences Corp. as of September 30, 2022 is -0.51.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2022-09-30	-0.46	-0.56	-1.03	-0.45	-0.51
2022-06-30	-0.51	-0.60	-0.94	-0.11	-0.46
2022-03-31	-0.53	-0.60	-1.02	-0.23	-0.46
2021-12-31	-0.45	-0.52	-0.93	-0.36	-0.57
2021-09-30	-0.26	-0.31	-0.28	0.01	-0.37
2021-06-30	-0.29	-0.34	-0.37	-0.21	-0.40
2021-03-31	-0.29	-0.33	-0.35	-0.12	-0.40
2020-12-31	-0.29	-0.34	-0.36	0.19	-0.37
2020-09-30	-0.32	-0.36	-0.55	-0.05	-0.51
2020-06-30	-0.34	-0.38	-0.56	-0.09	-0.50
2020-03-31	-0.59	-0.79	-0.58	0.10	-0.53

Gross Margins

The gross margin for Khiron Life Sciences Corp. as of September 30, 2022 is 0.41.
The net margin for Khiron Life Sciences Corp. as of September 30, 2022 is -1.90.
The operating margin for Khiron Life Sciences Corp. as of September 30, 2022 is -1.08.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2022-09-30	0.41	-1.90	-1.08
2022-06-30	0.42	-1.87	-1.14
2022-03-31	0.43	-2.26	-1.37
2021-12-31	0.50	-2.59	-1.60
2021-09-30	0.84	-1.37	-1.45
2021-06-30	0.89	-1.92	-1.87
2021-03-31	0.91	-2.27	-2.22
2020-12-31	0.87	-3.00	-2.94
2020-09-30	0.43	-3.73	-3.89
2020-06-30	0.35	-3.82	-4.00
2020-03-31	0.26	-4.00	-4.04